LAMTOR1 decreased exosomal PD-L1 to enhance immunotherapy efficacy in non-small cell lung cancer

Autor: Bo Wu, Xin Huang, Xiang Shi, Meixi Jiang, Hongxu Liu, Li Zhao

Publikováno v: Molecular Cancer, Vol 23, Iss 1, Pp 1-16 (2024)

Abstract Great progress has been made in utilizing immune checkpoint blockade (ICB) for the treatment of non-small-cell lung cancer (NSCLC). Therapies targeting programmed cell death protein 1 (PD-1) and its ligand PD-L1, expressed on tumor cells, ha

Externí odkaz: https://doaj.org/article/038d8fcd5095467189bb7199ca6ca4ae

Traditional chinese medicine injections with activating blood circulation, equivalent effect of anticoagulation or antiplatelet, for acute myocardial infarction: A systematic review and meta-analysis of randomized clinical trials

Autor: Xueyan Sun, Jiaping Chen, Juju Shang, Hongxu Liu, Xiang Li, Yan Lou, Huiwen Zhou

Publikováno v: Complementary Therapies in Medicine, Vol 82, Iss , Pp 103039- (2024)

Background: Traditional Chinese medicine injection for Activating Blood Circulation (TCMi-ABC), which exhibits comparable anticoagulant and antiplatelet effects, is commonly used as an adjuvant treatment for acute myocardial infarction (AMI) in China

Externí odkaz: https://doaj.org/article/eaa98fcc6345496f9bd33cea794909c1

Expert consensus on treatment for stage III non‐small cell lung cancer

Autor: Yi‐Long Wu, Shun Lu, Qinghua Zhou, Li Zhang, Ying Cheng, Jie Wang, Buhai Wang, Chengping Hu, Lizhu Lin, Wenzhao Zhong, Yong Song, Nong Yang, Xiaorong Dong, Jian Zhao, Haihong Yang, Hui Guo, Xiaolong Yan, Hongxu Liu, Rui Ma, Jie Lin, Siyang Liu, Chun Chen, Lifeng Wang, Chengzhi Zhou, Ming Zhou, Fang Wu, Xue‐Ning Yang, Yingying Du, Yu Yao, Yang Shao, Shaodong Hong, Jiuwei Cui, Xueping Quan, Rongrong Chen, Jiayan Wu, Jiatao Zhang, Jianya Zhou, Binchao Wang, Chao Cheng, Huijuan Wang, Jingjing Liu, Lin Wu, Yan Huang, Yukun Kuang, Yongchang Zhang, Jia Hu, Jinji Yang, Weineng Feng, Wenmei Su, Yun Fan, Fan Yang, Ming Chen, Kejing Tang, Yi Pan, Peng Shen, Anwen Liu, Haibo Zhang, Wenhua Liang, Qing Zhou, Zhiyong Ma, Xiuyu Cai, Hui Liu, Longfei Chen, Shaokun Chuai, Jianzhen Shan, Yanfang Zheng, Changxuan You, Xiaoxia Zhu, Li Li, Tongmei Zhang, Haiyan Tu, Wurong Lin, Xuchao Zhang, Penghui Zhou, Zunfu Ke, Huiying Liang

Publikováno v: Medicine Advances, Vol 1, Iss 1, Pp 3-13 (2023)

Abstract Stage III non‐small cell lung cancer (NSCLC) encompasses a group of diseases with high heterogeneity. Such patients should actively receive comprehensive treatments. It is imperative for all stage III NSCLC patients to receive consultation

Externí odkaz: https://doaj.org/article/628a61c2e0b7401888cbceb96adb32ce

Pan-mediastinal neoplasm diagnosis via nationwide federated learning: a multicentre cohort study

Autor: Ruijie Tang, PhD, Hengrui Liang, PhD, Yuchen Guo, PhD, Zhigang Li, PhD, Zhichao Liu, MD, Xu Lin, PhD, Zeping Yan, BS, Jun Liu, PhD, Xin Xu, PhD, Wenlong Shao, PhD, Shuben Li, PhD, Wenhua Liang, ProfPhD, Wei Wang, PhD, Fei Cui, PhD, Huanghe He, PhD, Chao Yang, PhD, Long Jiang, PhD, Haixuan Wang, MD, Huai Chen, MD, Chenguang Guo, MD, Haipeng Zhang, MD, Zebin Gao, PhD, Yuwei He, PhD, Xiangru Chen, ME, Lei Zhao, PhD, Hong Yu, MD, Jian Hu, ProfPhD, Jiangang Zhao, MD, Bin Li, PhD, Ci Yin, MD, Wenjie Mao, MD, Wanli Lin, MD, Yujie Xie, MD, Jixian Liu, MD, Xiaoqiang Li, PhD, Dingwang Wu, MD, Qinghua Hou, MD, Yongbing Chen, PhD, Donglai Chen, PhD, Yuhang Xue, MD, Yi Liang, MD, Wenfang Tang, MD, Qi Wang, ProfPhD, Encheng Li, MD, Hongxu Liu, MD, Guan Wang, MD, Pingwen Yu, MD, Chun Chen, ProfPhD, Bin Zheng, PhD, Hao Chen, MD, Zhe Zhang, MD, Lunqing Wang, MD, Ailin Wang, MD, Zongqi Li, MD, Junke Fu, MD, Guangjian Zhang, MD, Jia Zhang, MD, Bohao Liu, MD, Jian Zhao, MD, Boyun Deng, MD, Yongtao Han, PhD, Xuefeng Leng, PhD, Zhiyu Li, MD, Man Zhang, MD, Changling Liu, MD, Tianhu Wang, MD, Zhilin Luo, MD, Chenglin Yang, MD, Xiaotong Guo, MD, Kai Ma, MD, Lixu Wang, MD, Wenjun Jiang, MD, Xu Han, MD, Qing Wang, MD, Kun Qiao, MD, Zhaohua Xia, MD, Shuo Zheng, MD, Chenyang Xu, MD, Jidong Peng, MD, Shilong Wu, MD, Zhifeng Zhang, MD, Haoda Huang, MD, Dazhi Pang, MD, Qiao Liu, BSN, Jinglong Li, MD, Xueru Ding, MD, Xiang Liu, MD, Liucheng Zhong, MD, Yutong Lu, MD, Feng Xu, PhD, Qionghai Dai, ProfPhD, Jianxing He, ProfPhD

Publikováno v: The Lancet: Digital Health, Vol 5, Iss 9, Pp e560-e570 (2023)

Summary: Background: Mediastinal neoplasms are typical thoracic diseases with increasing incidence in the general global population and can lead to poor prognosis. In clinical practice, the mediastinum's complex anatomic structures and intertype conf

Externí odkaz: https://doaj.org/article/4dca55b112774b0f8cd1255e5774a831

Effect of Traditional Chinese Medicine Cutaneous Regions Therapy as adjuvant treatment of chronic heart failure: A systematic review and meta-analysis

Autor: MingXuan Li, HongDian Li, HongXu Liu, XiaoLei Lai, Wenlong Xing, JuJu Shang

Publikováno v: Heliyon, Vol 9, Iss 5, Pp e16012- (2023)

Objective: To systematically evaluate the effectiveness of Traditional Chinese Medicine Cutaneous Regions Therapy (TCMCRT) as an adjunctive treatment for chronic heart failure. Methods: China National Knowledge Infrastructure (CNKI), Wanfang database

Externí odkaz: https://doaj.org/article/478a80a649564c738593ccb15363e8a8